Search clinical trials for: AdimFlu-S 2010-2011, inactivated

Total 657 results

Fundación Pública Andaluza para la Investigación...

Completed

15 Years Outcomes Following Bioprosthetic vs Mechanical Aortic Valve Replacement Between 50-65 Years (ANDALVALVE)

Surgery | Valve Heart Disease | Survival, Prosthesis

Spain
Liquidia Technologies, Inc.
Children's Hospital Medical Center, Cincinnati; Accelovance

Completed

A Study Evaluating the Safety and Tolerability of a Seasonal Influenza Vaccine Containing LIQ001 (LIfT)

Influenza

United States
Center for Human Reproduction
Foundation for Human Reproduction

Enrolling by invitation

Effect of Influenza Vaccination on IVF Outcomes - IVF (IVF-FluVac)

Infertility

United States
Adimmune Corporation

Completed

Immunogenicity and Safety Evaluation of QIS in Healthy Subjects

Influenza
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity of Fluzone® Quadrivalent and Fluzone® High-Dose, Influenza Vaccines, 2016-2017 Formulations

Influenza

United States
PharmaJet, Inc.

Completed

Jet Injection for Influenza (JIFI)

Influenza, Human

United States
Medical University of Lodz
GlaxoSmithKline

Not yet recruiting

Efficacy of Mepolizumab in Polish Patients With Severe Eosinophilic Asthma

Asthma; Eosinophilic

Poland
Adimmune Corporation

Completed

The Safety and Immune Response to Influenza Vaccination in Pregnant Women

Influenza

Taiwan
Seqirus

Completed

A Study to Assess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy Volunteers

Influenza

United Kingdom
Tel-Aviv Sourasky Medical Center

Unknown

Influenza Vaccination in Fibromyalgia Patients

Fibromyalgia Syndrome

Israel
British Columbia Centre for Disease Control
McGill University Health Centre/Research Institute of the McGill University... and other collaborators

Active, not recruiting

TITRE III: Influenza B Immunogenicity Investigation

Influenza

Canada
University of Oxford

Completed

Studying Movement Control in Parkinson's Disease Using Closed Loop Deep Brain Stimulation

Parkinson Disease

United Kingdom
McMaster University
Canadian Institutes of Health Research (CIHR)

Recruiting

Relative Impacts on Preventative Primary Care--a Longitudinal Evaluation of COVID-19:Phase 1 (RIPPLE-C)

Diabetes Mellitus | Chronic Kidney Diseases | Chronic Obstructive Pulmonary Disease | Osteoarthritis | Dementia | Congestive Heart Failure | Depression, Anxiety

Canada
Crucell Holland BV

Completed

Re-licensing Study to Assess Inflexal V Formulated With WHO Recommended Influenza Strains (2013-14)

Influenza

Switzerland
Sanofi Pasteur, a Sanofi Company

Completed

Safety and Immunogenicity Among Healthy Children Receiving Fluzone® Influenza Virus Vaccine (2012-2013 Formulation)

Influenza

United States
University of Oslo

Not yet recruiting

Early Intervention Coping Kids (TIM) Follow up Study (FOPPT4)

Depression | Anxiety Disorders
National Taiwan University Hospital

Unknown

Antibody Titer Analysis After H1N1 Vaccination in Pediatric Haemato-oncology Patients

Serology Analysis | Novel H1N1 Influenza Vaccination | Pediatric Haemato-oncology Patients

Taiwan
University of Toledo Health Science Campus

Active, not recruiting

Models for Improving Operating Room Productivity: Delays, Cancellations and Pre-admission Testing

Other Surgical Procedures

United States
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Plasmablast Trafficking and Antibody Response in Influenza Vaccination (SLVP021 2011-2014)

Influenza

United States
Hoffmann-La Roche

Completed

A Prospective Study to Evaluate the Specificity of the Cobas TaqScreen MPX Test for Use on the Cobas s 201 System for Screening Plasma Pools From Source Plasma Donors for the Presence of HBV DNA, HCV RNA, and HIV-1 RNA

Healthy Volunteer

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study to Assess the Immune Response and the Safety Profile of a High-Dose Quadrivalent Influenza Vaccine (QIV-HD) Compared to a Standard-Dose Quadrivalent Influenza Vaccine (QIV-SD) in Europeans Adults 60 Years of Age and Older

Healthy Volunteers | Influenza Immunization

France, Belgium, Germany, Italy, Netherlands, Poland
Guangdong Hengrui Pharmaceutical Co., Ltd

Completed

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics Pharmacodynamics of SHR-2010 by Intravenously/Subcutaneously in Healthy Subject

IgA Nephropathy

China
University Health Network, Toronto

Completed

High Dose vs. Standard Influenza Vaccine in Adult SOT

Influenza | Immunosuppression

Canada
GlaxoSmithKline

Completed

Immunogenicity and Safety of PrepandrixTM in Korean Subjects Aged 18 to 60 Years Old

Influenza

Korea, Republic of
Sanofi Pasteur, a Sanofi Company

Completed

Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects (FBP00004)

Healthy Volunteers | Influenza Immunisation

United States
Ology Bioservices

Completed

Adult Safety Study of 2009/2010 Seasonal Influenza Vaccine

Influenza

Austria, Belgium
Assistance Publique - Hôpitaux de Paris

Completed

Efficacy and Safety of Influenza Vaccine During Sarcoidosis (SARCOVAC)

Influenza Vaccine | Sarcoidosis

France
University of British Columbia
Dr. Xue Chen (Janny) Ke; Dr. Alana Flexman; Dr. Stephan Schwarz; Dr. P. Shaun MacDonald

Completed

Anesthesia Technique and Lower Limb Revascularization Patency

Regional Anesthesia, Vascular Grafting, Vascular Patency

Canada
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

B-cell Immunity to Influenza (SLVP017)- Year 1, 2009

Influenza

United States
University of Michigan
Planned Parenthood Federation of America; National Opinion Research Center

Recruiting

Michigan Contraceptive Access, Research, and Evaluation Study Children: Phase 1 (M-CARES-K)

Pregnancy

United States
University Hospital, Basel, Switzerland

Completed

Long--term Outcome Analysis of Fracture--related Infections (Re_FRI)

Fracture-associated Infection (FAI)

Switzerland
Sanofi Pasteur, a Sanofi Company

Completed

Study of Quadrivalent Influenza Vaccine Among Children

Influenza

United States
Assiut University

Not yet recruiting

Renal Resistive Index as a Predictor of Renal Involvement in Rheumatoid Arthritis

Rheumatoid Arthritis
Samsung Medical Center
Ybrain Inc.

Unknown

A Pilot Study of tDCS for Mild Cognitive Impairment

Mild Cognitive Impairment

Korea, Republic of
Incheon St.Mary's Hospital
Ybrain Inc.

Completed

Study of tDCS for Mild Cognitive Impairment

Mild Cognitive Impairment

Korea, Republic of
Sanofi Pasteur, a Sanofi Company

Completed

Collection of Serum Samples From Children and Older Adults Receiving the 2019-2020 Formulations of Fluzone® Quadrivalent and Fluzone® High-Dose Influenza Vaccines, Respectively (GRC00097)

Influenza

United States
Sanofi Pasteur, a Sanofi Company

Completed

Study of Influenza Vaccine (Split Virion, Inactivated) Northern Hemisphere 2009-2010 Formulation

Influenza

Switzerland
Jounce Therapeutics, Inc.

Terminated

Study of PD-1 Inhibitor JTX-4014 Alone and in Combination With Vopratelimab in Biomarker-selected Subjects With Metastatic NSCLC After One Prior Platinum-containing Regimen (SELECT)

NSCLC

Latvia, Bosnia and Herzegovina, Russian Federation, Romania, Turkey, Belarus, Bulgaria, Croatia, Hungary, Serbia, Slovakia, Ukraine, Georgia, Moldova, Republic of
University of Aarhus
Aarhus University Hospital; Danish Cancer Society; University of Southern Denmark

Completed

Health and Coping Prior to Ovarian Cancer Surgery

Health and Coping Undergoing Ovarian Cancer Surgery. | Cancer Rehabilitation

Denmark
Ybrain Inc.
Gangnam Severance Hospital; Severance Hospital; CHA University; Hallym University... and other collaborators

Completed

The Effect of tDCS in Patients With Moderate to Severe Major Depressive Disorder

Major Depressive Disorder

Korea, Republic of
Samsung Medical Center
Ybrain Inc.

Unknown

A Pilot Study of tDCS for Mild to Moderate Alzhemier's Disease

Alzheimer's Disease

Korea, Republic of
The Medicines Company

Completed

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of MDCO-2010 in Patients Undergoing Elective Coronary Artery Bypass Graft Surgery

Cardiopulmonary Bypass | Coronary Artery Bypass Graft
Pharmazz, Inc.

Not yet recruiting

A Study to Assess Safety and Efficacy of Centhaquine as a Resuscitative Agent

Hypovolemic Shock
Pharmazz, Inc.

Completed

A Study to Determine the Safety, Tolerability and Pharmacokinetics of PMZ-2010 (Centhaquin) in Healthy Volunteers

Healthy

India
Pharmazz, Inc.

Not yet recruiting

Multicentric, Randomized Study to Assess Safety and Efficacy of Centhaquine in COVID-19 Patients With ARDS

COVID-19 Acute Respiratory Distress Syndrome
National Taiwan University Hospital
L'Oreal

Unknown

Evaluate the Lightening Effect of the Whitening Cosmetic Product BEX-2011

Solar Lentigines

Taiwan
QurAlis Corporation

Recruiting

A Study Evaluating the Safety and Tolerability of QRL-201 in ALS

Amyotrophic Lateral Sclerosis

Canada, Germany, Netherlands, Ireland, United Kingdom, Belgium
Ybrain Inc.

Recruiting

The Efficacy and Safety of tDCS in Patients With Mild Dementia

Mild Dementia

Korea, Republic of
Oryzon Genomics S.A.
Alzheimer's Drug Discovery Foundation

Completed

Testing the Safety and Preliminary Efficacy of the New Drug ORY-2001 in Mild to Moderate Alzheimer's Disease (ETHERAL-US)

Mild to Moderate Alzheimer's Disease

United States
Stanford University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Recruiting

Clinical Trial of a Novel Small Molecule EBNA1 Inhibitor, VK 2019, in Patients With Epstein Barr Virus (EBV)-Positive Nasopharyngeal Cancer (NPC) and Other Epstein-Barr Virus (EBV)-Associated Cancers, With Pharmacokinetic and Pharmacodynamic Correlative Studies

Nasopharyngeal Cancer | Epstein-Barr Virus Related Carcinoma

United States

Search clinical trials for: AdimFlu-S 2010-2011, inactivated

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Paraguay

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations